References
Centers for Disease Control and Prevention: Overweight and Obesity: Data and Statistics. Available at http://www.cdc.gov/obesity/data/index.html. Accessed November 2009.
Centers for Disease Control and Prevention: Press Release: Number of People with Diabetes Increases to 24 Million. Estimates of Diagnosed Diabetes Now Available for all U.S. Counties. Available at http://www.cdc.gov/media/pressrel/2008/r080624.htm. Accessed November 2009.
Gaede P, Vedel P, Larsen N, et al.: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383–393.
Turner RC, Cull CA, Stratton IM, et al.: Overview of 6 year’s therapy of type II diabetes: a progressive disease. Diabetes 1995, 44:1249–1258.
The Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545–2559.
ADVANCE Collaboration Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560–2572.
Duckworth W, Abraira C, Moritz T, et al.: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129–139.
Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004, 291:335–342.
Ford ES, Li C, Little RR, et al.: Trends in A1c concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004. Diabetes Care 2008, 31:102–104.
Brown JB, Nicholas GA, Perry A: The burden of treatment failure in type 2 diabetes. Diabetes Care 2004, 27:1535–1540.
Mateo JF, Gil-Guillen VF, Mateo E, et al.: Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Int J Clin Pract 2006, 60:422–428.
Kahn SE, Haffner SM, Heise MA, et al.: Glycemic durability of rosiglitazone, metformin or glyburide monotherapy. N Engl J Med 2006, 355:2427–2443.
Nathan DM, Buse JB, Davidson MB, et al.: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193–203.
Rodbard H, Jellinger P, Davidson J, et al.: Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009, 15:541–559.
Disclosure
No potential conflict of interest relevant to this article was reported.